Eam Global Investors LLC Aurinia Pharmaceuticals Inc. Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$14.12 - $18.33 $2.22 Million - $2.88 Million
-157,128 Closed
0 $0
Q1 2020

May 13, 2020
SELL
$11.34 - $21.46 $32,387 - $61,289
-2,856 Reduced 1.79%
157,128 $2.28 Million
Q4 2019

Feb 10, 2020
BUY
$3.88 - $21.42 $620,737 - $3.43 Million
159,984 New
159,984 $3.24 Million

Others Institutions Holding AUPH

# of Institutions
208
Shares Held
58.6M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email